Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

cyanosis, cyantosis COVID-positive infant.

Chest X-ray of a  2-month-old infant diagnosed with COVID-19 showing an enlarged heart, bibasilar opacities caused by collapse of the lower sections of lungs, and right upper lobe atelectasis (lung collapse). Find more information and figures on this patient case.

 

News | Coronavirus (COVID-19) | December 02, 2020
COVID-19 Can Impact Hearts in Young Children
December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury...
read more
COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States. #DAIC

COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States.

Feature | Cardiovascular Business | December 01, 2020 | Dave Fornell, Editor
Most Popular Cardiology Technology Content in November 2020
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
read more
The Clarius PA HD hand-held, wireless ultrasound scanner is now available for high resolution cardiac imaging with the release of the Clarius Ultrasound App 7.3 for iOS and Android smart devices.
News | Cardiovascular Ultrasound | November 30, 2020
High-Definition Handheld Ultrasound Scanner Now Enables Rapid Bedside Cardiac Exams
November 30, 2020 — The Clarius PA HD hand-held, wireless ultrasound scanner is now available for high resolution...
read more
Videos | Coronavirus (COVID-19) | November 18, 2020
VIDEO: Lingering Myocardial Involvement After COVID-19 Infection
Aaron Baggish, M.D., director of the cardiovascular performance program, Massachusetts General Hospital. He was on a...
read more
Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. #AHA #AHA20 #AHA2020 #COVID19 #Coronavirus #SARSCoV2

Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. 

News | Coronavirus (COVID-19) | November 18, 2020 | Dave Fornell, Editor
COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent
November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed...
read more
Black patient being tested for COVID-19 using a nasal swab PCR test. black adults with COVID-19 were far more likely to be hospitalized than their white counterparts according to data from the AHA COVID-19 Cardiovascular Disease Registry. #AHA #AHA20 #AHA2020 #COVID19 #SARSCoV2

Black patient being tested for COVID-19 using a nasal swab PCR test. Black adults with COVID-19 were far more likely to be hospitalized than their white counterparts according to new data from the AHA COVID-19 Cardiovascular Disease Registry. 

Feature | Coronavirus (COVID-19) | November 18, 2020
COVID-19 Cardiovascular Registry Details Disparities Among Hospitalized Patients
November 18, 2020 -- A new American Heart Association (AHA) collaborative model for COVID-19 (SARS-CoV-2) research,...
read more
Videos | Coronavirus (COVID-19) | November 12, 2020
VIDEO: Video Game Helps Diagnose COVID-19 Patients and Manage Their Cardiac Complications
Eric Gantwerker, M.D., vice president and medical director at clinical video game simulator company Level Ex, and...
read more
Videos | Coronavirus (COVID-19) | November 10, 2020
VIDEO: How to Reduce COVID Exposure, Speed Exams and Cut Readmissions in Cardiology Departments
Keith Ellis, M.D., is the director of cardiovascular services and the director of the Chest Pain Center at Houston...
read more
The impact of COVID-19 on the heart and cardiovascular system is being evaluated in a new clinic for post-COVID patients to monitor and manage their cardiac recovery.
News | Coronavirus (COVID-19) | November 10, 2020
Cedars-Sinai Launches Clinic to Manage Long-Term Heart Health Issues in COVID-19 Patients
November 10, 2020 — The Smidt Heart Institute at Cedars-Sinai Hospital in Los Angeles has established a specialized...
read more
NIH trial, the Outcomes Related to COVID-19 treated with Hydroxychloroquine among Inpatients with symptomatic Disease (ORCHID), showed no difference in deaths between placebo and hydroxychloroquine. Getty Images
News | Coronavirus (COVID-19) | November 09, 2020 | Dave Fornell, Editor
Hydroxychloroquine Does Not Help Hospitalized COVID-19 Patients
November 9, 2020 — A National Institutes of Health (NIH) clinical trial evaluating the safety and effectiveness of...
read more
The American Heart Association, AHA, late-breaking sessions, trials, studies. #AHA #AHA20 #AHA2020
Feature | AHA | November 20, 2020 | Dave Fornell, Editor
American Heart Association 2020 Late-breaking Trial Presentations 
Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual...
read more
The Abiomed Breethe OXY-1 System has received U.S. FDA 510(k) clearance. 
Feature | ECMO Systems | October 26, 2020
FDA Clears Abiomed Compact ECMO System for COVID-19 and Cardiogenic Shock Patients
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for an all-in-...
read more
Videos | Coronavirus (COVID-19) | October 20, 2020
VIDEO: Use of Impella in COVID-19 Patients
Chuck Simonton, M.D., chief medical officer at Abiomed, explains when advanced hemodynamic support in required in COVID...
read more
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit. Research examines telehealth, healthcare disparities, as well as impacts on interventional cardiology, patient-centered care.
News | Coronavirus (COVID-19) | October 14, 2020
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit
October 14, 2020 — American College of Cardiology (ACC) Quality Summit virtual meeting Oct. 8-9, 2020, featured several...
read more
Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

News | TCT | October 14, 2020
ACC and CRF Create the Martin B. Leon Center for Cardiovascular Transformation
October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are...
read more
© Copyright Wainscot Media. All Rights Reserved.